Moyamoya Disease

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Rita Xu	+ 624 word(s)	624	2020-12-15 07:31:52

Cite

If you have any further questions, please contact Encyclopedia Editorial Office.

Select a Style

Xu, R. Moyamoya Disease. Encyclopedia. Available online: https://encyclopedia.pub/entry/4284 (accessed on 27 September 2026).

Xu R. Moyamoya Disease. Encyclopedia. Available at: https://encyclopedia.pub/entry/4284. Accessed September 27, 2026.

Xu, Rita. "Moyamoya Disease" Encyclopedia, https://encyclopedia.pub/entry/4284 (accessed September 27, 2026).

Xu, R. (2020, December 23). Moyamoya Disease. In Encyclopedia. https://encyclopedia.pub/entry/4284

Xu, Rita. "Moyamoya Disease." Encyclopedia. Web. 23 December, 2020.

Moyamoya Disease

Edit

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/condition/moyamoya-disease

Moyamoya disease is a disorder of blood vessels in the brain, specifically the internal carotid arteries and the arteries that branch from them.

genetic conditions

References

Achrol AS, Guzman R, Lee M, Steinberg GK. Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus. 2009 Apr;26(4):E4. doi:10.3171/2009.1.FOCUS08302. Review.
Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, Wang GT, RegaladoES, Steinberg GK, Shendure J, Bamshad MJ; University of Washington Center forMendelian Genomics, Grotta JC, Nickerson DA, Pannu H, Milewicz DM. RNF213 rarevariants in an ethnically diverse population with Moyamoya disease. Stroke. 2014 Nov;45(11):3200-7. doi: 10.1161/STROKEAHA.114.006244.
Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T.Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as aSusceptibility Gene. J Stroke. 2014 May;16(2):65-72. doi:10.5853/jos.2014.16.2.65.
Hayashi K, Horie N, Suyama K, Nagata I. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan. ClinNeurol Neurosurg. 2013 Jul;115(7):930-3. doi: 10.1016/j.clineuro.2012.09.020.
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J,Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A,Tsuchiya S, Tominaga T, Matsubara Y, Kure S. A genome-wide association studyidentifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011Jan;56(1):34-40. doi: 10.1038/jhg.2010.132.
Kronenburg A, Braun KP, van der Zwan A, Klijn CJ. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2014Jan;14(1):423. doi: 10.1007/s11910-013-0423-7. Review.
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A,Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A. Identification of RNF213 as a susceptibility gene for moyamoyadisease and its possible role in vascular development. PLoS One.2011;6(7):e22542. doi: 10.1371/journal.pone.0022542.
Smith ER, Scott RM. Moyamoya: epidemiology, presentation, and diagnosis.Neurosurg Clin N Am. 2010 Jul;21(3):543-51. doi: 10.1016/j.nec.2010.03.007.Review.

©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Genetics & Heredity

Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Rita Xu

View Times: 838

Entry Collection: MedlinePlus

Update Date: 23 Dec 2020

Table of Contents

Video Upload Options

References